HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $69,857,786 | +286.6% | 603,836 | +99.7% | 0.54% | +250.3% |
Q2 2023 | $18,070,069 | +535.7% | 302,384 | +368.5% | 0.16% | +453.6% |
Q1 2023 | $2,842,513 | -84.1% | 64,542 | -61.6% | 0.03% | -81.1% |
Q4 2022 | $17,831,142 | +79.7% | 168,032 | +4.8% | 0.15% | +78.3% |
Q3 2022 | $9,923,000 | +7.3% | 160,343 | +38.3% | 0.08% | -7.8% |
Q2 2022 | $9,245,000 | +51.4% | 115,921 | +99.7% | 0.09% | +63.6% |
Q1 2022 | $6,106,000 | +167.3% | 58,040 | +173.8% | 0.06% | +161.9% |
Q4 2021 | $2,284,000 | -69.8% | 21,200 | -69.3% | 0.02% | -73.1% |
Q3 2021 | $7,570,000 | +53.4% | 69,109 | +31.1% | 0.08% | +50.0% |
Q2 2021 | $4,936,000 | +29.0% | 52,717 | +26.8% | 0.05% | +10.6% |
Q1 2021 | $3,826,000 | +124.5% | 41,563 | +78.4% | 0.05% | +104.3% |
Q4 2020 | $1,704,000 | -83.4% | 23,300 | -82.4% | 0.02% | -88.3% |
Q3 2020 | $10,291,000 | +106.6% | 132,475 | +47.8% | 0.20% | +192.5% |
Q2 2020 | $4,982,000 | +523.5% | 89,624 | +232.3% | 0.07% | +34.0% |
Q1 2020 | $799,000 | -51.4% | 26,967 | -40.6% | 0.05% | +25.0% |
Q4 2019 | $1,645,000 | -74.0% | 45,409 | -80.4% | 0.04% | -78.4% |
Q3 2019 | $6,315,000 | +261.9% | 231,982 | +219.8% | 0.18% | +198.4% |
Q2 2019 | $1,745,000 | – | 72,539 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |